Calcium channels: the potential therapeutic targets for inflammatory bone destruction of rheumatoid arthritis

Robin Park, Jong Dae Ji

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

Introduction: Inflammatory bone resorption causes progressive joint destruction which ultimately leads to functional disability in rheumatoid arthritis (RA). The primary cell responsible for bone resorption is the osteoclast, which means it is a potential therapeutic target against bone destruction. In fact, experimental and clinical findings suggest that blockade of osteoclast differentiation and function is highly effective in inhibiting bone destruction in RA. Discussion and conclusion: In this report, we show several lines of experimental evidence which suggest that a variety of Ca2+ channels are essential in osteoclast differentiation and function, and present a hypothesis that modulation of Ca2+ channels is a highly effective therapeutic strategy in preventing osteoclast-induced structural damage in RA.

Original languageEnglish
Pages (from-to)347-354
Number of pages8
JournalInflammation Research
Volume65
Issue number5
DOIs
Publication statusPublished - 2016 May 1

Fingerprint

Osteoclasts
Calcium Channels
Rheumatoid Arthritis
Bone and Bones
Bone Resorption
Therapeutics
Joints

Keywords

  • Calcium channel
  • Inflammation
  • Osteoclast
  • Rheumatoid arthritis

ASJC Scopus subject areas

  • Immunology
  • Pharmacology

Cite this

Calcium channels : the potential therapeutic targets for inflammatory bone destruction of rheumatoid arthritis. / Park, Robin; Ji, Jong Dae.

In: Inflammation Research, Vol. 65, No. 5, 01.05.2016, p. 347-354.

Research output: Contribution to journalReview article

@article{79298fff209b4e3facdbfb7c4fa851b6,
title = "Calcium channels: the potential therapeutic targets for inflammatory bone destruction of rheumatoid arthritis",
abstract = "Introduction: Inflammatory bone resorption causes progressive joint destruction which ultimately leads to functional disability in rheumatoid arthritis (RA). The primary cell responsible for bone resorption is the osteoclast, which means it is a potential therapeutic target against bone destruction. In fact, experimental and clinical findings suggest that blockade of osteoclast differentiation and function is highly effective in inhibiting bone destruction in RA. Discussion and conclusion: In this report, we show several lines of experimental evidence which suggest that a variety of Ca2+ channels are essential in osteoclast differentiation and function, and present a hypothesis that modulation of Ca2+ channels is a highly effective therapeutic strategy in preventing osteoclast-induced structural damage in RA.",
keywords = "Calcium channel, Inflammation, Osteoclast, Rheumatoid arthritis",
author = "Robin Park and Ji, {Jong Dae}",
year = "2016",
month = "5",
day = "1",
doi = "10.1007/s00011-016-0920-7",
language = "English",
volume = "65",
pages = "347--354",
journal = "Inflammation Research",
issn = "1023-3830",
publisher = "Birkhauser Verlag Basel",
number = "5",

}

TY - JOUR

T1 - Calcium channels

T2 - the potential therapeutic targets for inflammatory bone destruction of rheumatoid arthritis

AU - Park, Robin

AU - Ji, Jong Dae

PY - 2016/5/1

Y1 - 2016/5/1

N2 - Introduction: Inflammatory bone resorption causes progressive joint destruction which ultimately leads to functional disability in rheumatoid arthritis (RA). The primary cell responsible for bone resorption is the osteoclast, which means it is a potential therapeutic target against bone destruction. In fact, experimental and clinical findings suggest that blockade of osteoclast differentiation and function is highly effective in inhibiting bone destruction in RA. Discussion and conclusion: In this report, we show several lines of experimental evidence which suggest that a variety of Ca2+ channels are essential in osteoclast differentiation and function, and present a hypothesis that modulation of Ca2+ channels is a highly effective therapeutic strategy in preventing osteoclast-induced structural damage in RA.

AB - Introduction: Inflammatory bone resorption causes progressive joint destruction which ultimately leads to functional disability in rheumatoid arthritis (RA). The primary cell responsible for bone resorption is the osteoclast, which means it is a potential therapeutic target against bone destruction. In fact, experimental and clinical findings suggest that blockade of osteoclast differentiation and function is highly effective in inhibiting bone destruction in RA. Discussion and conclusion: In this report, we show several lines of experimental evidence which suggest that a variety of Ca2+ channels are essential in osteoclast differentiation and function, and present a hypothesis that modulation of Ca2+ channels is a highly effective therapeutic strategy in preventing osteoclast-induced structural damage in RA.

KW - Calcium channel

KW - Inflammation

KW - Osteoclast

KW - Rheumatoid arthritis

UR - http://www.scopus.com/inward/record.url?scp=84957535418&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84957535418&partnerID=8YFLogxK

U2 - 10.1007/s00011-016-0920-7

DO - 10.1007/s00011-016-0920-7

M3 - Review article

C2 - 26852086

AN - SCOPUS:84957535418

VL - 65

SP - 347

EP - 354

JO - Inflammation Research

JF - Inflammation Research

SN - 1023-3830

IS - 5

ER -